Conference call with management on February 3 at 2:30 pm hosted by Cantor. Webcast Link
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTMX:
- CytomX Therapeutics initiated with a Buy at Guggenheim
- CytomX Therapeutics price target raised to $10 from $6.50 at Piper Sandler
- CytomX Therapeutics price target raised to $8 from $6 at Barclays
- CytomX Therapeutics: Asymmetric Upside Ahead of Pivotal CX-2051 Colorectal Cancer Data Supports Reiterated Buy and $10 Target
- CytomX Therapeutics announces business update, 2026 milestones